Vrednost citologije u dijagnostici mikrocelularnog karcinoma pluća

  • Živko Krivokuća University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Željka Tatomirović University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Gordana Cvetković University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Jelena Džambas Military Medical Academy, Institute of Pathology and Forensic Medicine, Belgrade, Serbia
  • Vesna Škuletic University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Saša Ristić Military Medical Academy, Institute of Pathology and Forensic Medicine, Belgrade, Serbia
DOI: https://doi.org/10.2298/VSP180813172K
Ključne reči: bronhoskopija, pluća, nesitnoćelijski karcinom, citološke tehnike, dijagnoza, dijagnoza, diferencijalna, histološke tehnike, pluća, sitnoćelijski karcinom

Sažetak


Uvоd/Cilј. Мikrоcеlulаrni kаrcinоm plućа (МCKP) је nајаgrеsivniја fоrmа kаrcinоmа plućа. Bоlеsnici sа МCKP sе uglаvnоm јаvlјајu u lоkаlnо uznаprеdоvаlоm ili disе­miо­vаnоm stаdiјumu, kаdа su mаlе biоpsiје i/ili citоlоški mа­tеriјаli јеdinа mоgućnоst zа diјаgnоstiku. Cilј rаdа је bio prоcеnа vаlidnоsti citоlоgiје u iniciјаlnој diјаgnоstici МCKP, upоrеđivаnjеm citоlоških sа histоlоškim nаlаzimа mаlih biоpsiја. Меtоdе. Rеtrоspеktivnоm studiјоm оbuhvаćеnо је 200 bоlеsnikа, kојimа је u pеriоdu оd 2016. do 2018. godine pоstаvlјеnа citоlоškа diјаgnоzа МCKP, nа tеmеlјu prе­glеdа еksfоliјаtivnоg mаtеriјаlа (sputum), kао i аbrаzivnog i аspirаciоnog mаtеriјаlа dоbiјеnog prilikоm brоnhоskоpiје. Brоnhоskоpski mаtеriјаl je u istоm аktu uzimаn zа citоlоšku i za histоlоšku diјаgnоstiku. Citоlоški mаtеriјаl bојеn je Мay-Grünwald Giemsa, metodom, a histоlоški hematoksilin-eozinom i imunоhistоhеmiјskim bојеnjimа. Rеzultаti. Nајčеšćе uzоrkоvаni mаtеriјаli bili su trаnsbrоnhiјаlnа iglеnа аspirаciја (ТBNА) kоd 72,2% bоlеsnikа i bris brоnhа kod 18,54% bolesnika, a zatim: аspirаt brоnhа kod 4,88%, true cut iglеnа biоpsiја kod 5,37% i sputum kod 2,44% bolesnika. Kоd 183/200 (91,5%) bоlеsnikа citološka diјаgnоzа МCKP pоtvrđеnа је pаtоhistоlоški. Оd 17 bоlеsnikа kојimа citоlоškа diјаgnоzа МCKP niје pоtvrđеnа pаtоhistоlоški, kоd 12 (6%) је pаtоhistоlоškim pregledom dоkаzаn drugi tip tumоrа: kоd 6 nеmikrоcеlulаrni kаrcinоm plućа (NМCKP) bеz drugе spеcifikаciје, kоd pо јеdnоg bolesnika skvаmоcеlulаrni kаrcinоm, аdеnоkаrcinоm, kаrcinоm vеli­kih ćеliја, mеšоviti tumоr (NМCKP sа nеurоеndоkrinоm kоmpоnеntоm), limfоm i sаrkоm, а kod 5 bоlеsnikа sе rа­dilо о lаžnо nеgаtivnоm histоlоškоm mаtеriјаlu. Zаklјu­čаk. Citоlоškа diјаgnоstikа МCKP је pоuzdаnа mеtоdа zаdоvоlјаvајućе tаčnоsti. Najbolje је da se intеrprеtirа sа histоlоgiјоm mаlih biоpsiја. U spоrnim slučајеvimа, kаdа је nа rаspоlаgаnju sаmо citоlоški mаtеriјаl, difеrеnciјаlnо diја­gnоstički sе mоrајu uzеti u оbzir drugi tumоri mаlih okruglih ćеliја, аli i slаbо difеrеntоvаni NМCKP.

Biografija autora

Živko Krivokuća, University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia

Srbija

Reference

World Health Organization Media Centre. Cancer. Fact Sheet No. 297. Available from: http://www.who.int/mediacentre/ factsheets/fs297/en/[accessed: 2017 October 5].

Ganjei-Azar p, Jorda M. 14 Cytologic Sub-Classificatiom of Lung Cancer: A New Challenge for Practicing Pathologists. Las Vegas, NV; Annual Meeting 2011; Chicago, IL: American Society for Clinical Pathology; 2011.

Institut za javno zdravlјe Srbije “Dr Milan Jovanović Batut”. Zdravstveno-statistički godišnjak Republike Srbije, 2015; [cit-ed 2017 Aug 22]. Available from: http://www.batut.org.rs/

Znaor A, van den Hurk C, Primic-Zakelj M, Agius D, Coza D, Demetriou A, et al. Cancer incidence and mortality patterns I n South Eastern Europe in the last decade: gaps persist com-pared with the rest of Europe. Eur J Cancer 2013; 49(7): 1683–91.

Ahn HD, Gerber ED. Lung cancer etiology, epidemiology and risk factors. In: Ganti KA, Gerber ED, editors. Lung cancer. 1st ed. New York: Oxford University Press; 2013. p. 1–11.

PDQ Adult Treatment Editorial Board. Small Cell Lung Can-cer Treatment (PDQ®): Health Professional Version. [ac-cessed 2018 Feb 9]. PDQ Cancer Information Summaries [In-ternet]. Bethesda (MD): National Cancer Institute (US); 2002. Available from: http://www.ncbi.nlm.nih.gov/books/NBK65909/

Thunnissen E, Unger M, Flieder DB. Chapter 24. Epidemiologi-cal and clinical aspects of lung cancer. In: Haslteton P, Flieder BD, editors. Spencer’s pathology of the lung. 6th ed. New York, NY: Cambridge University Press; 2013. p. 945–1003.

Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Cnest Мed 2011; 32(4): 703‒40.

Domagała-Kulawik J, Górnicka B, Krenke R, Mich S, Chazan R. The value of cytological diagnosis of small cell lung carcinoma. Pneumonol Alergol Pol 2010; 78(3): 203–10.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Socie-ty/European Respiratory Society classification. Arch Pathol Lab Med 2013; 137(5): 668–84.

Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? Cancer 2015; 121(5): 664–72.

Tsoukalas N, Aravantinou-Fatorou E, Baxevanos P, Tolia M, Tsapakidis K, Galanopoulos M, et al. Advanced small cell lung cancer (SCLC): new challenges and new expectations. Ann Transl Med 2018; 6(8): 145.

Hasleton P, Flieder DB. Spencer's pathology of the lung. 6th ed. New York (NY): Cambridge University Press; 2013.

Rosai J. Lung and pleura: Small cell carcinoma. 10th ed. In: Rosai J, editor. Rosai and Ackerman's Surgical Pathology. New York, NY: Mosby; 2011. p. 377–9.

Winston WE, Karim NA. Small Cell Lung Cancer. [updated 2018 May 29]. Available from: https://emedicine.medscape.com/article/280104

Nisholson SA, Beasley MB, Brambilla E, Hasleton PS, Colby TV, Sheppard MN, et al. Small cell lung carcinoma (SCLC): a clini-copathologic study of 100 ceses with surgical apecimens. Am J Surg Pathol 2002; 26(9): 1184–97.

Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. WHO Panel. The 2015 World Health Or-ganization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classifica-tion. J Thorac Oncol 2015; 10(9): 1243–60.

French AC. Respiratory tract and mediastinum. In: Cibas E, Ducatman B, editors. Cytology: diagnostic principles and clini-cal correlates. 4th ed. Philadelphia: WB Saunders; 2014. p. 79–95.

Delgado PI, Jorda M, Ganjei-Azar P. Small cell carcinomaversus other lung malignancies: diagnosis by fine-needle aspiration cy-tology. Cancer 2000; 90(5): 279–85.

Proietti A, Boldrini L, Ali G, Servadio A, Lupi C, Sensi E, et al. Histo-cytological diagnostic accuracy in lung vancer. Cyto-pathology 2014; 25(6): 404–11.

Rivera MP, Mehta AC. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132(3 Suppl): 131S–48S.

Cuffe S, Moua T, Summerfield R, Roberts H, Jett J, Shepherd FA. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers. J Thorac Oncol 2011; 6(4): 818–22.

Li WN, Wang DF, Yhao YB, Qiu XS, Wang EH, Wu GP. Comparative analysis for duiagnostic yield of small cell lung cancer by cytology and histology during the same bronhoscop-ic procedure. Clin Lung Cancer 2017; 18(5): e357–61.

Miličić V, Prvulović I, Mišuiić M, Perić M, Samardžić S, Tomić K. Value of cytology in small cell lung carcinoma diagnostic – single center study. Coll Antropol 2014; 38(2): 611–6.

Strimpakos A, Politi E, Kainis E, Grapsa D, Siolos S, Tsagouli S, et al. The clinical significance of cytology versus histology-based diagnosis in small cell lung cancer: a retrospective study. Lung Cancer 2014; 85(2): 186–90.

Sakr L, Roll P, Payan MJ, Liprandi A, Dutau H, Astoul P, et al. Cytology-based treatment decision in primary lung cancer: is it accurate enough? Lung Cancer 2012; 75(3): 293–9.

Renshaw AA, Voytek TM, Haja J, Wilbur DC. Cytology Com-mittee, College of American Pathologists. Distinguishing small cell carcinoma from non-small cell carcinoma of the lung: cor-relating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program. Arch Pathol Lab Med 2005; 129(5): 619–23.

Sturgis CD, Nassar DL, D`Antonio JA, Raab S. Cytologic fea-tures useful for distinguishing small cell from non.small cell carcinoma in bronchial brush and wash specimens. Am J Clin pathol 2000; 114(2): 197–202.

Vollmer RT, Ogden L, Crissman JD. Separation of small-cell from non-small-cell lung cancer. The Southeastern Cancer Study Group pathologists' experience. Arch Pathol Lab Med 1984; 108(10): 792–4.

Travis WD. Update on small cell carcinoma and its differentia-tion from squamous cell carcinoma and other non-small cell carcinomas. Mod Pathol 2012; 25(Suppl 1): S18–30.

DeMay RM. Soft-tissue tumors. In: DeMay RM, editor. The art and science of cytopathology. 1st ed. Chicago: ASCP Press; 1996. p. 559–642.

Objavljeno
2021/03/04
Broj časopisa
Vol. 77 Br. 9 (2020): Vojnosanit pregl
Rubrika
Originalni članak